Generic Biologics Could Save $71 Billion Over 10 Years, Report Says

Executive Briefing Series
A A
A pathway for creating and marketing generic biologics could help health plan sponsors and patients save $71 billion over the next 10 years, according to an Express Scripts report.

To View This Article:

Login